120 related articles for article (PubMed ID: 2381507)
21. P300 topography in Alzheimer's disease.
Holt LE; Raine A; Pa G; Schneider LS; Henderson VW; Pollock VE
Psychophysiology; 1995 May; 32(3):257-65. PubMed ID: 7784534
[TBL] [Abstract][Full Text] [Related]
22. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
[TBL] [Abstract][Full Text] [Related]
23. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
24. Auditory event-related potentials in subcortical vascular cognitive impairment and in Alzheimer's disease.
Muscoso EG; Costanzo E; Daniele O; Maugeri D; Natale E; Caravaglios G
J Neural Transm (Vienna); 2006 Nov; 113(11):1779-86. PubMed ID: 17039300
[TBL] [Abstract][Full Text] [Related]
25. Modality-specific changes in P300 parameters in patients with dementia of the Alzheimer type.
Pokryszko-Dragan A; Słotwiński K; Podemski R
Med Sci Monit; 2003 Apr; 9(4):CR130-4. PubMed ID: 12709671
[TBL] [Abstract][Full Text] [Related]
26. Cognitive brain potentials and psychological deficits in Alzheimer's dementia and Korsakoff's amnesic syndrome.
Blackwood DH; St Clair DM; Blackburn IM; Tyrer GM
Psychol Med; 1987 May; 17(2):349-58. PubMed ID: 3602227
[TBL] [Abstract][Full Text] [Related]
27. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
28. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
Foster NL; VanDerSpek AF; Aldrich MS; Berent S; Hichwa RH; Sackellares JC; Gilman S; Agranoff BW
J Cereb Blood Flow Metab; 1987 Aug; 7(4):415-20. PubMed ID: 3497161
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography and familial Alzheimer's disease: a pilot study.
Guze BH; Hoffman JM; Mazziotta JC; Baxter LR; Phelps ME
J Am Geriatr Soc; 1992 Feb; 40(2):120-3. PubMed ID: 1740595
[TBL] [Abstract][Full Text] [Related]
30. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
32. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
33. Latency variability of the components of auditory event-related potentials to infrequent stimuli in aging, Alzheimer-type dementia, and depression.
Patterson JV; Michalewski HJ; Starr A
Electroencephalogr Clin Neurophysiol; 1988; 71(6):450-60. PubMed ID: 2460326
[TBL] [Abstract][Full Text] [Related]
34. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
Gungor HA; Yildiz A; Aydin F; Gungor F; Boz A; Ozkaynak S
J Neurol Sci; 2005 Jul; 234(1-2):47-53. PubMed ID: 15950243
[TBL] [Abstract][Full Text] [Related]
35. An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET.
Murphy DG; Bottomley PA; Salerno JA; DeCarli C; Mentis MJ; Grady CL; Teichberg D; Giacometti KR; Rosenberg JM; Hardy CJ
Arch Gen Psychiatry; 1993 May; 50(5):341-9. PubMed ID: 8489323
[TBL] [Abstract][Full Text] [Related]
36. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
[TBL] [Abstract][Full Text] [Related]
37. High-resolution PET studies in Alzheimer's disease.
Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
[TBL] [Abstract][Full Text] [Related]
38. Normal latency of the P300 event-related potential in mild-to-moderate Alzheimer's disease and depression.
Kraiuhin C; Gordon E; Coyle S; Sara G; Rennie C; Howson A; Landau P; Meares R
Biol Psychiatry; 1990 Sep; 28(5):372-86. PubMed ID: 2207218
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease: metabolic uncoupling of associative brain regions.
Rapoport SI; Horwitz B; Haxby JV; Grady CL
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):540-5. PubMed ID: 3491664
[TBL] [Abstract][Full Text] [Related]
40. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
Klunk WE; Engler H; Nordberg A; Wang Y; Blomqvist G; Holt DP; Bergström M; Savitcheva I; Huang GF; Estrada S; Ausén B; Debnath ML; Barletta J; Price JC; Sandell J; Lopresti BJ; Wall A; Koivisto P; Antoni G; Mathis CA; Långström B
Ann Neurol; 2004 Mar; 55(3):306-19. PubMed ID: 14991808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
